# Littelfuse Inc: financial statements, quarterly LFUS · Nasdaq · CIK 889331 · [Technology](/sectors/technology.md) · fiscal year ends Dec 26 Pages: [Overview](/companies/lfus.md) · [Financials](/companies/lfus/financials.md) · [Filings](/companies/lfus/filings.md) · [Insiders](/companies/lfus/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lfus/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [534 d](/filings/0001628280-26-009585.md) | [535](/filings/0000889331-25-000099.md) | [558](/filings/0001628280-25-036650.md) | [567](/filings/0001628280-25-047026.md) | [530 d](/filings/0001628280-26-009585.md) | [554](/filings/0001628280-26-031041.md) | [613](/filings/0001628280-26-050481.md) | [625](/filings/0001628280-26-067807.md) | [594 d](/filings/0001628280-26-009585.md) | [657](/filings/0001628280-26-031041.md) | [739](/filings/0001628280-26-050481.md) | [767](/filings/0001628280-26-067807.md) | | Cost of revenue | $m | [340 d](/filings/0001628280-26-009585.md) | [348](/filings/0000889331-25-000099.md) | [351](/filings/0001628280-25-036650.md) | [351](/filings/0001628280-25-047026.md) | [353 d](/filings/0001628280-26-009585.md) | [347](/filings/0001628280-26-031041.md) | [381](/filings/0001628280-26-050481.md) | [384](/filings/0001628280-26-067807.md) | [368 d](/filings/0001628280-26-009585.md) | [403](/filings/0001628280-26-031041.md) | [433](/filings/0001628280-26-050481.md) | [448](/filings/0001628280-26-067807.md) | | Gross profit | $m | [194 d](/filings/0001628280-26-009585.md) | [188](/filings/0000889331-25-000099.md) | [207](/filings/0001628280-25-036650.md) | [216](/filings/0001628280-25-047026.md) | [177 d](/filings/0001628280-26-009585.md) | [207](/filings/0001628280-26-031041.md) | [232](/filings/0001628280-26-050481.md) | [241](/filings/0001628280-26-067807.md) | [226 d](/filings/0001628280-26-009585.md) | [254](/filings/0001628280-26-031041.md) | [306](/filings/0001628280-26-050481.md) | [319](/filings/0001628280-26-067807.md) | | Research and development | $m | [25.2 d](/filings/0001628280-26-009585.md) | [27.7](/filings/0000889331-25-000099.md) | [27.1](/filings/0001628280-25-036650.md) | [26.5](/filings/0001628280-25-047026.md) | [26.5 d](/filings/0001628280-26-009585.md) | [26.0](/filings/0001628280-26-031041.md) | [26.4](/filings/0001628280-26-050481.md) | [27.3](/filings/0001628280-26-067807.md) | [27.1 d](/filings/0001628280-26-009585.md) | [29.7](/filings/0001628280-26-031041.md) | [31.0](/filings/0001628280-26-050481.md) | [29.7](/filings/0001628280-26-067807.md) | | Selling, general and administrative | $m | [84.6 d](/filings/0001628280-26-009585.md) | [86.1](/filings/0000889331-25-000099.md) | [93.4](/filings/0001628280-25-036650.md) | [83.9](/filings/0001628280-25-047026.md) | [87.0 d](/filings/0001628280-26-009585.md) | [87.7](/filings/0001628280-26-031041.md) | [95.5](/filings/0001628280-26-050481.md) | [99.6](/filings/0001628280-26-067807.md) | [99.0 d](/filings/0001628280-26-009585.md) | [99.3](/filings/0001628280-26-031041.md) | [121](/filings/0001628280-26-050481.md) | [115](/filings/0001628280-26-067807.md) | | Operating income | $m | [64.5 d](/filings/0001628280-26-009585.md) | [55.0](/filings/0000889331-25-000099.md) | [65.5](/filings/0001628280-25-036650.md) | [87.8](/filings/0001628280-25-047026.md) | [(49.5) d](/filings/0001628280-26-009585.md) | [70.2](/filings/0001628280-26-031041.md) | [92.8](/filings/0001628280-26-050481.md) | [97.4](/filings/0001628280-26-067807.md) | [(223) d](/filings/0001628280-26-009585.md) | [101](/filings/0001628280-26-031041.md) | [120](/filings/0001628280-26-050481.md) | [153](/filings/0001628280-26-067807.md) | | Interest expense | $m | [10.1 d](/filings/0000889331-24-000034.md) | [9.6](/filings/0000889331-24-000129.md) | [10.0](/filings/0001628280-25-036650.md) | [9.8](/filings/0001628280-25-047026.md) | [9.4 d](/filings/0001628280-26-009585.md) | [8.9](/filings/0001628280-26-031041.md) | [8.6](/filings/0001628280-26-050481.md) | [8.6](/filings/0001628280-26-067807.md) | [8.3 d](/filings/0001628280-26-009585.md) | [7.0](/filings/0001628280-26-031041.md) | [5.7](/filings/0001628280-26-050481.md) | [5.7](/filings/0001628280-26-067807.md) | | Income tax | $m | [16.1 d](/filings/0001628280-26-009585.md) | [7.3](/filings/0000889331-25-000099.md) | [15.7](/filings/0001628280-25-036650.md) | [19.7](/filings/0001628280-25-047026.md) | [9.1 d](/filings/0001628280-26-009585.md) | [16.4](/filings/0001628280-26-031041.md) | [20.9](/filings/0001628280-26-050481.md) | [25.2](/filings/0001628280-26-067807.md) | [12.9 d](/filings/0001628280-26-009585.md) | [21.6](/filings/0001628280-26-031041.md) | [27.7](/filings/0001628280-26-050481.md) | [34.8](/filings/0001628280-26-067807.md) | | Net income | $m | [42.9 d](/filings/0001628280-26-009585.md) | [48.5](/filings/0001628280-25-047026.md) | [45.5](/filings/0001628280-25-047026.md) | [58.1](/filings/0001628280-25-047026.md) | [(51.8) d](/filings/0001628280-26-009585.md) | [43.6](/filings/0001628280-26-067807.md) | [57.3](/filings/0001628280-26-067807.md) | [69.5](/filings/0001628280-26-067807.md) | [(242) d](/filings/0001628280-26-009585.md) | [75.1](/filings/0001628280-26-067807.md) | [89.4](/filings/0001628280-26-067807.md) | [115](/filings/0001628280-26-067807.md) | | Diluted EPS | $ per share | not reported | [1.93](/filings/0000889331-25-000099.md) | [1.82](/filings/0001628280-25-036650.md) | [2.32](/filings/0001628280-25-047026.md) | not reported | [1.75](/filings/0001628280-26-031041.md) | [2.30](/filings/0001628280-26-050481.md) | [2.77](/filings/0001628280-26-067807.md) | not reported | [2.96](/filings/0001628280-26-031041.md) | [3.49](/filings/0001628280-26-050481.md) | [4.49](/filings/0001628280-26-067807.md) | | Basic EPS | $ per share | not reported | [1.95](/filings/0000889331-25-000099.md) | [1.83](/filings/0001628280-25-036650.md) | [2.34](/filings/0001628280-25-047026.md) | not reported | [1.76](/filings/0001628280-26-031041.md) | [2.32](/filings/0001628280-26-050481.md) | [2.80](/filings/0001628280-26-067807.md) | not reported | [3.00](/filings/0001628280-26-031041.md) | [3.53](/filings/0001628280-26-050481.md) | [4.54](/filings/0001628280-26-067807.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [556](/filings/0001628280-26-009585.md) | [562](/filings/0000889331-25-000099.md) | [562](/filings/0001628280-25-036650.md) | [630](/filings/0001628280-25-047026.md) | [725](/filings/0001628280-26-009585.md) | [619](/filings/0001628280-26-031041.md) | [685](/filings/0001628280-26-050481.md) | [815](/filings/0001628280-26-067807.md) | [563](/filings/0001628280-26-067807.md) | [482](/filings/0001628280-26-031041.md) | [628](/filings/0001628280-26-050481.md) | [825](/filings/0001628280-26-067807.md) | | Current assets | $m | [1,409](/filings/0000889331-25-000039.md) | [1,444](/filings/0000889331-24-000129.md) | [1,464](/filings/0000889331-24-000161.md) | [1,563](/filings/0000889331-24-000191.md) | [1,552](/filings/0001628280-26-009585.md) | [1,433](/filings/0000889331-25-000099.md) | [1,542](/filings/0001628280-25-036650.md) | [1,674](/filings/0001628280-25-047026.md) | [1,435](/filings/0001628280-26-067807.md) | [1,376](/filings/0001628280-26-031041.md) | [1,584](/filings/0001628280-26-050481.md) | [1,813](/filings/0001628280-26-067807.md) | | Total assets | $m | [3,995](/filings/0000889331-25-000039.md) | [3,943](/filings/0000889331-24-000129.md) | [3,925](/filings/0000889331-24-000161.md) | [4,062](/filings/0000889331-24-000191.md) | [3,892](/filings/0001628280-26-009585.md) | [3,888](/filings/0000889331-25-000099.md) | [4,066](/filings/0001628280-25-036650.md) | [4,174](/filings/0001628280-25-047026.md) | [3,957](/filings/0001628280-26-067807.md) | [3,858](/filings/0001628280-26-031041.md) | [4,012](/filings/0001628280-26-050481.md) | [4,226](/filings/0001628280-26-067807.md) | | Current liabilities | $m | [375](/filings/0000889331-25-000039.md) | [405](/filings/0000889331-24-000129.md) | [418](/filings/0000889331-24-000161.md) | [440](/filings/0000889331-24-000191.md) | [434](/filings/0001628280-26-009585.md) | [370](/filings/0000889331-25-000099.md) | [380](/filings/0001628280-25-036650.md) | [419](/filings/0001628280-25-047026.md) | [533](/filings/0001628280-26-067807.md) | [527](/filings/0001628280-26-031041.md) | [574](/filings/0001628280-26-050481.md) | [680](/filings/0001628280-26-067807.md) | | Total liabilities | $m | [1,515](/filings/0000889331-25-000039.md) | [1,472](/filings/0000889331-24-000129.md) | [1,459](/filings/0000889331-24-000161.md) | [1,489](/filings/0000889331-24-000191.md) | [1,478](/filings/0001628280-26-009585.md) | [1,431](/filings/0000889331-25-000099.md) | [1,467](/filings/0001628280-25-036650.md) | [1,502](/filings/0001628280-25-047026.md) | [1,531](/filings/0001628280-26-067807.md) | [1,343](/filings/0001628280-26-031041.md) | [1,394](/filings/0001628280-26-050481.md) | [1,501](/filings/0001628280-26-067807.md) | | Long-term debt | $m | [858](/filings/0000889331-25-000039.md) | [801](/filings/0000889331-24-000129.md) | [796](/filings/0000889331-24-000161.md) | [800](/filings/0000889331-24-000191.md) | [789](/filings/0001628280-26-009585.md) | [788](/filings/0000889331-25-000099.md) | [793](/filings/0001628280-25-036650.md) | [789](/filings/0001628280-25-047026.md) | [706](/filings/0001628280-26-067807.md) | [531](/filings/0001628280-26-031041.md) | [530](/filings/0001628280-26-050481.md) | [530](/filings/0001628280-26-067807.md) | | Current portion of debt | $m | [14.0](/filings/0000889331-25-000039.md) | [65.8](/filings/0000889331-24-000129.md) | [67.7](/filings/0000889331-24-000161.md) | [67.8](/filings/0000889331-24-000191.md) | [67.6](/filings/0001628280-26-009585.md) | [17.7](/filings/0000889331-25-000099.md) | [17.7](/filings/0001628280-25-036650.md) | [17.0](/filings/0001628280-25-047026.md) | [96.2](/filings/0001628280-26-067807.md) | [100](/filings/0001628280-26-031041.md) | [100](/filings/0001628280-26-050481.md) | [100](/filings/0001628280-26-067807.md) | | Shareholders' equity | $m | [2,480](/filings/0000889331-25-000039.md) | [2,471](/filings/0000889331-24-000129.md) | [2,465](/filings/0000889331-24-000161.md) | [2,573](/filings/0000889331-24-000191.md) | [2,413](/filings/0001628280-26-009585.md) | [2,456](/filings/0000889331-25-000099.md) | [2,598](/filings/0001628280-25-036650.md) | [2,671](/filings/0001628280-25-047026.md) | [2,426](/filings/0001628280-26-067807.md) | [2,514](/filings/0001628280-26-067807.md) | [2,618](/filings/0001628280-26-067807.md) | [2,724](/filings/0001628280-26-067807.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [144 d](/filings/0001628280-26-009585.md) | [57.2](/filings/0000889331-25-000099.md) | [69.4 d](/filings/0001628280-25-036650.md) | [80.4 d](/filings/0001628280-25-047026.md) | [161 d](/filings/0001628280-26-009585.md) | [65.8](/filings/0001628280-26-031041.md) | [82.5 d](/filings/0001628280-26-050481.md) | [147 d](/filings/0001628280-26-067807.md) | [139 d](/filings/0001628280-26-009585.md) | [80.3](/filings/0001628280-26-031041.md) | [146 d](/filings/0001628280-26-050481.md) | [230 d](/filings/0001628280-26-067807.md) | | Capital expenditure | $m | [23.0 d](/filings/0001628280-26-009585.md) | [15.5](/filings/0000889331-25-000099.md) | [19.1 d](/filings/0001628280-25-036650.md) | [15.4 d](/filings/0001628280-25-047026.md) | [25.8 d](/filings/0001628280-26-009585.md) | [23.1](/filings/0001628280-26-031041.md) | [9.9 d](/filings/0001628280-26-050481.md) | [15.7 d](/filings/0001628280-26-067807.md) | [18.9 d](/filings/0001628280-26-009585.md) | [14.1](/filings/0001628280-26-031041.md) | [18.9 d](/filings/0001628280-26-050481.md) | [14.5 d](/filings/0001628280-26-067807.md) | | Dividends paid | $m | [16.2 d](/filings/0001628280-26-009585.md) | [16.2](/filings/0000889331-25-000099.md) | [16.1 d](/filings/0001628280-25-036650.md) | [17.4 d](/filings/0001628280-25-047026.md) | [17.4 d](/filings/0001628280-26-009585.md) | [17.3](/filings/0000889331-25-000099.md) | [17.3 d](/filings/0001628280-25-036650.md) | [18.6 d](/filings/0001628280-25-047026.md) | [18.7 d](/filings/0001628280-26-009585.md) | [18.8](/filings/0001628280-26-031041.md) | [19.0 d](/filings/0001628280-26-050481.md) | [20.3 d](/filings/0001628280-26-067807.md) | | Share repurchases | $m | [0.0 d](/filings/0001628280-26-009585.md) | [16.1](/filings/0000889331-25-000099.md) | [24.7 d](/filings/0001628280-25-036650.md) | [0.0 d](/filings/0001628280-25-047026.md) | [0.0 d](/filings/0001628280-26-009585.md) | [27.4](/filings/0001628280-26-031041.md) | [0.2 d](/filings/0001628280-26-050481.md) | [0.0 d](/filings/0001628280-26-067807.md) | [0.0 d](/filings/0001628280-26-009585.md) | [0.0](/filings/0001628280-26-031041.md) | [0.0 d](/filings/0001628280-26-050481.md) | [0.0 d](/filings/0001628280-26-067807.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [25.1](/filings/0000889331-24-000129.md) | [25.1](/filings/0000889331-24-000161.md) | [25.1](/filings/0000889331-24-000191.md) | [25.1](/filings/0000889331-25-000099.md) | [25.0](/filings/0001628280-25-036650.md) | [25.0](/filings/0001628280-25-047026.md) | [25.0](/filings/0001628280-26-031041.md) | [24.9](/filings/0001628280-26-050481.md) | [25.1](/filings/0001628280-26-067807.md) | [25.4](/filings/0001628280-26-031041.md) | [25.6](/filings/0001628280-26-050481.md) | [25.7](/filings/0001628280-26-067807.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 25,403,547 at 2026-10-23, from the cover of the [10-Q filed 2026-10-28](/filings/0001628280-26-067807.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:19 ET. No prices; not investment advice.